These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15911328)

  • 21. Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis.
    Tentori L; Lacal PM; Muzi A; Dorio AS; Leonetti C; Scarsella M; Ruffini F; Xu W; Min W; Stoppacciaro A; Colarossi C; Wang ZQ; Zhang J; Graziani G
    Eur J Cancer; 2007 Sep; 43(14):2124-33. PubMed ID: 17714938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a miniaturized assay for the high-throughput screening program for poly(ADP-ribose) polymerase-1.
    Lee S; Koo HN; Lee BH
    Methods Find Exp Clin Pharmacol; 2005 Nov; 27(9):617-22. PubMed ID: 16357945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.
    Martin-Oliva D; Aguilar-Quesada R; O'valle F; Muñoz-Gámez JA; Martínez-Romero R; García Del Moral R; Ruiz de Almodóvar JM; Villuendas R; Piris MA; Oliver FJ
    Cancer Res; 2006 Jun; 66(11):5744-56. PubMed ID: 16740713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical poly(ADP-ribose) polymerase inhibitors for the treatment of cancer.
    Lewis C; Low JA
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1051-6. PubMed ID: 18058575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to kill tumor cells with inhibitors of poly(ADP-ribosyl)ation.
    Mangerich A; Bürkle A
    Int J Cancer; 2011 Jan; 128(2):251-65. PubMed ID: 20853319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly(ADP-ribose) polymerase inhibitor therapeutic effect: are we just scratching the surface?
    Hottiger MO
    Expert Opin Ther Targets; 2015; 19(9):1149-52. PubMed ID: 26212149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PARP inhibitors: new tools to protect from inflammation.
    Giansanti V; Donà F; Tillhon M; Scovassi AI
    Biochem Pharmacol; 2010 Dec; 80(12):1869-77. PubMed ID: 20417190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PARP inhibitors blaze a trail in difficult-to-treat cancers.
    Kling J
    Nat Biotechnol; 2009 Sep; 27(9):784-6. PubMed ID: 19741614
    [No Abstract]   [Full Text] [Related]  

  • 29. Dual regulation of AP-2alpha transcriptional activation by poly(ADP-ribose) polymerase-1.
    Li M; Naidu P; Yu Y; Berger NA; Kannan P
    Biochem J; 2004 Aug; 382(Pt 1):323-9. PubMed ID: 15170387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
    Bryant HE; Helleday T
    Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(ADP-ribose) polymerase 1 inhibition prevents interleukin-1β-induced inflammation in human osteoarthritic chondrocytes.
    Sun Y; Zhou L; Lv D; Liu H; He T; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2015 Jun; 47(6):422-30. PubMed ID: 25926140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The promising role of poly(ADP-ribose) polymerase inhibitors in prostate cancer.
    Aragon-Ching JB
    Asian J Androl; 2016; 18(4):592-3. PubMed ID: 26908063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly(ADP-ribose) polymerase-1 protects excessive DNA strand breaks from deterioration during repair in human cell extracts.
    Parsons JL; Dianova II; Allinson SL; Dianov GL
    FEBS J; 2005 Apr; 272(8):2012-21. PubMed ID: 15819892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of poly(ADP-ribose) polymerase in cancer.
    Plummer ER
    Curr Opin Pharmacol; 2006 Aug; 6(4):364-8. PubMed ID: 16753340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of telomerase activity by reduction of poly(ADP-ribosyl)ation of TERT and TEP1/TP1 expression in HeLa cells with knocked down poly(ADP-ribose) polymerase-1 (PARP-1) gene.
    Ghosh U; Das N; Bhattacharyya NP
    Mutat Res; 2007 Feb; 615(1-2):66-74. PubMed ID: 17141279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the prevention of plaque rupture as a new strategy for prevention of acute arterial cardiovascular events.
    Levi M; Stroes E
    Cardiovasc Res; 2008 Jun; 78(3):407-8. PubMed ID: 18413321
    [No Abstract]   [Full Text] [Related]  

  • 37. Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity.
    Tentori L; Muzi A; Dorio AS; Bultrini S; Mazzon E; Lacal PM; Shah GM; Zhang J; Navarra P; Nocentini G; Cuzzocrea S; Graziani G
    Eur J Cancer; 2008 Jun; 44(9):1302-14. PubMed ID: 18440222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [PARP inhibitors: significant progress in cancer therapy].
    Dantzer F; Noel G; Schreiber V
    Bull Cancer; 2011 Mar; 98(3):277-90. PubMed ID: 21459712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways.
    Wang M; Wu W; Wu W; Rosidi B; Zhang L; Wang H; Iliakis G
    Nucleic Acids Res; 2006; 34(21):6170-82. PubMed ID: 17088286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Poly(ADP-ribose) polymerase (PARP): physiological and pathological roles].
    Makogon NV; Aleksieieva IM
    Fiziol Zh (1994); 2012; 58(3):95-112. PubMed ID: 22946318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.